Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

The results of this study suggest a modest increase in the risk of nonarteritic anterior ischemic optic neuropathy among individuals ...

The diabetes medication Ozempic has emerged as an unexpected player in the weight loss arena, sparking intense ...

You can rotate injections between your stomach, upper arm, and thigh. Semaglutide is a prescription type 2 diabetes medication. It’s sold under the brand names Wegovy and Ozempic. You’ll need ...

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

One of the reasons it is prescribed is to help improve blood sugar in adults with type 2 diabetes. Semaglutide was a top-selling drug in 2023, and its popularity only continues to grow ...

Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released. Semaglutide is a glucagon-like ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...